This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Protalix BioTherapeutics Inc.
PLX : AMEX : Health Care

$4.18 -0.13 | -3.02%
Today's Range: 4.12 - 4.40
Avg. Daily Volume: 219,000
04/16/14 - 4:01 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
PLX PROTALIX BIOTHERAPEUTICS INC 4.49 420.17 n/m 10.44 -70.23
OSIR OSIRIS THERAPEUTICS INC 13.48 461.30 449.33 24.31 209.69
XOMA XOMA CORP 4.30 459.58 n/m 35.45 4.94
DNDN DENDREON CORP 2.78 441.95 n/m 283.75 -12.84
TKMR TEKMIRA PHARMACEUTICALS CORP 19.84 436.12 n/m 15.69 11.22
DVAX DYNAVAX TECHNOLOGIES CORP 1.61 423.20 n/m 11.25 15.82
AMAG AMAG PHARMACEUTICALS INC 17.82 388.48 n/m 80.86 -5.30
ZIOP ZIOPHARM ONCOLOGY INC 3.86 388.15 n/m 0.80 0.00
SVA SINOVAC BIOTECH LTD 6.56 361.40 54.67 72.52 47.35
CUR NEURALSTEM INC 4.11 354.36 n/m 0.11 -73.04
SNSS SUNESIS PHARMACEUTICALS INC 5.84 350.95 n/m 7.96 111.93
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PLX Ind Avg S&P 500
n/m 43.67 18.29

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs